NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cue Biopharma (CUE)

Technical Analysis Report for NASDAQ stock CUE Cue Biopharma. Dated: 11 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma

Cue Biopharma Opened at 28.38 and Closed at: 28.74, which is 2.57% of previous session's close. It moved within a range of 27.50 and 28.89
The session was a Bullish session with an average volume of 122700, which is -16.63% of previous session's volumes.

• There is some positive change in the mid term trend, but its too soon to jump onto conclusions.
• The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Golden cross was found 4 days back on short term averages

Support for tomorrow is 28.12 and resistance for tomorrow is 29.51
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 27.86, 26.99 resistance for tomorrow's hourly charts is 29.25, 29.77

10 Day SMA for Cue Biopharma (CUE) is 28.12 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Cue Biopharma (CUE) is 27.53 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Cue Biopharma (CUE) is 29.38 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 27.42 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Cue Biopharma is 13.89 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Cue Biopharma is at 27.53 and 200 DMA is at 13.89, while 50 DMA and 100 DMA are at 29.38 and 27.42 respectively

Cue Biopharma (CUE) moving average of 20 SMA is at 27.53 and 20 EMA is at 28.07

Cue Biopharma (CUE) moving average of 50 SMA is at 29.38 and 50 EMA is at 27.74

Cue Biopharma (CUE) moving average of 100 SMA is at 27.42 and 100 EMA is at 24.39

Cue Biopharma (CUE) moving average of 200 SMA is at 13.89 and 200 EMA is at 17.89

Vertex Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 17.88% more returns!

Veru Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Veru Inc, about 5.34% more returns!

Staar Surgical has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Staar Surgical, about 2.51% more returns!

Endra Life has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Endra Life, about 41.69% more returns!

Liquidia Technologies has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Liquidia Technologies, about 5.62% more returns!

Ligand Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Ligand Pharmaceuticals, about 12.52% more returns!

Lifevantage Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Lifevantage Corporation, about 9.87% more returns!

Orthopediatrics Corp has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 4.91% more returns!

Iradimed Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Iradimed Corporation, about 10.52% more returns!

Inmune Bio has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Inmune Bio, about 18.26% more returns!

Cue Biopharma has performed better than Genprex Inc in short term. Holding Cue Biopharma could be a better choice for now!

Arbutus Biopharma has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 25.6% more returns!

Adma Biologics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Adma Biologics, about 13.43% more returns!

Biolinerx has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Biolinerx, about 6.9% more returns!

Biomerica Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Biomerica Inc, about 57.73% more returns!

Collplant Holdings has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Collplant Holdings, about 976.57% more returns!

Cytosorbents Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Cytosorbents Corporation, about 1518.46% more returns!

Cue Biopharma Technical analysis of indicators

Price action analysis of Cue Biopharma (CUE) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Cue Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Cue Biopharma in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a SELL signal for Cue Biopharma in short term but SELL signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Cue Biopharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 28.51 and Cue Biopharma CUE stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.

Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CUE Experts View which covers a lot of information including buying and selling signals

CUE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet